Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
GKB Ophthalmics Limited (NSE: GKB), ISIN INE265D01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GKB last traded at ₹60.00 (-4.75%), with a 52-week range of ₹55.01 to ₹76.02 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 51.15%, FIIs 1.79%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 35/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.